InvestorsHub Logo
icon url

cabel

01/15/16 2:19 PM

#137161 RE: noretreat #137157

Well, I hope that the ovarian phase 2 trial can start this year. I also hope to see an article published this year, but I don't think that is going to be a major impact. It seems to me that DF is still looking for clearer results. Safety, the primary objective of phase 1, is no longer a question.



Still looking for clearer results,... alot of positive stuff came out of DF about K,...

One that came to mind is they said it appears that K is positive even for cases when p53 is not the problem!

I wonder why they don't just write up the trial,... start a phase 2 and see if they can answer their queries during a more advanced trial,...?
icon url

Jhawker

01/15/16 4:24 PM

#137173 RE: noretreat #137157

Thanks but when they are only dosing once a week they must realize that the results wouldn't be optimized so why continue enrolling really sick patients if they aren't seeing any benefit?